NEUMOLOGÍA PEDIÁTRICA

16 / 49

C o n t e n i d o d i s p o n i b l e e n h t t p : / / www. n e umo l o g i a - p e d i a t r i c a . cl
Neumol Pediatr 2018; 13 (2): 48-55
53
Evaluación de la disnea asociada al ejercicio
5
asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051)
asthma/asthgdln.htm (Accessed on December 04, 2014).
22. Bonini M, Di Mambro C, Calderon MA, et al. Betab-agonists for exercise-induced asthma. Cochrane Database Syst Rev 2013;
:CD003564.
23. Hancox RJ, Subbarao P, Kamada D, et al. Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care
Med 2002; 165:1068.
24. Inman MD, O’Byrne PM. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care
Med 1996; 153:65.
25. Pearlman DS, van Adelsberg J, Philip G, et al. Onset and duration of protection against exercise-induced bronchoconstriction by a
single oral dose of montelukast. Ann Allergy Asthma Immunol 2006; 97:98.
26. Leff JA, Busse WW, Pearlman D, et al. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and
exercise-induced bronchoconstriction. N Engl J Med 1998; 339:147.
27. Diego G. Peroni, Lydia Pescollderungg, et alt. Time-effect of montelukast on protection against exercise-induced bronchoconstriction,
Respiratory Medicine, Volume 105, Issue 12, 2011,Pages 1790-1797.
28. Bianco S, Vaghi A, Robuschi M, Pasargiklian M. Prevention of exercise-induced bronchoconstriction by inhaled frusemide. Lancet
1988; 2:252.
29. Melillo E, Woolley KL, Manning PJ, et al. Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects.
Am J Respir Crit Care Med 1994; 149:1138.
30. Shimizu T, Mochizuki H, Shigeta M, Morikawa A. Effect of inhaled indomethacin on exercise-induced bronchoconstriction in
children with asthma. Am J Respir Crit Care Med 1997; 155:170.
31. Ahmed T, Gonzalez BJ, Danta I. Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin. Am
J Respir Crit Care Med 1999; 160:576.
32. Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms
of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional
surveys. Lancet 2006;368:733-43
33. Blaiss M. The burden of allergic rhinitis and allergic rhinoconjunctivitis on adolescents: a literature review. Ann Allergy Asthma
Immunol. 2018 Apr 4. S1081-1206
34. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008
update Allergy 2008; 63(suppl 86):8-160
35. Eccles R, Windom H. Upper airway re exes and involvement of the lower airways. In: Corren J, Togias A, Bousquet J, Lenfant C,
editors. Upper and lower respiratory disease lung biology in health and disease, Vol. 181. NY: Marcel Dekker, 2004:87–99
36. Shaaban R, Zureik M, Soussan D, Neukirch C, Heinrich J, Sunyer J, et al. Rhinitis and onset of asthma: a longitudinal population-
based study. Lancet (2008) 372:1049–57.10.1016/S0140-6736
37. Brozek et al Allergic Rhinitis and its impact on asthma (ARIA) guidelines – 2016 revision. J Allergy Clin Immunol 2016; 140 (4):
950-958
38. Hseu A, Sandler M, Ericson D et al. Paradoxical vocal fold motion in children presenting with exercise induced dyspnea. Int J
Pediatr Otorhinolaryngol. 2016; 90:165–169.
39. Kenn K Balkissoon R Vocal cord dysfunction: what do we know? Eur Respir J 2011; 37: 194–200
40. Morrison M, Rammage L, Emami A. The irritable larynx syndrome. J Voice 1999; 13: 447–455.
41. Tilles SA. Vocal cord dysfunction in children and adolescents. Curr Allergy Asthma Rep 2003; 3: 467–472.
42. Goldberg BJ, Kaplan MS. Non-asthmatic respiratory symptomatology. Curr Opin Pulm Med 2000; 6: 26–30.
43. Ayres JG, Gabbott PLA, Vocal cord dysfunction and laryngeal hyperresponsiveness: a function of altered autonomic balance?
Thorax 2002;57:284-285.
44. Tilles, S. A., Ayars, A. G., Picciano, J. F., & Altman, K. (2013). Exercise induced vocal cord dysfunction and exercise-induced
laryngomalacia in children and adolescents: The same clinical syndrome? Annals of Allergy, Asthma & Immunology, 111(5), 342-346.
45. Chiang T, Marcinow AM, deSilva BW, Ence BN, Lindsey SE, Forrest LA Exercise-induced paradoxical vocal fold motion disorder:
diagnosis and management Laryngoscope. 2013 Mar;123(3):727-31. Epub 2012 Oct 24.
46. Sánchez I, Navarro H, Méndez M, et al. Clinical characteristics of children with tracheobronchial anomalies. Pediatr Pulmonol
2003; 35:288.
47. Saraswatula A, McShane D, Tideswell D, Burke GA, Williams DM, Nicholson JC, Murray MJ. Mediastinal masses masquerading as
common respiratory conditions of childhood: a case series. Eur J Pediatr. 2009 Nov;168(11):1395-9.
48. Heyer CM, Nuesslein TG, Jung D, et al. Tracheobronchial anomalies and stenoses: detection with low-dose multidetector CT with
virtual tracheobronchoscopy--comparison with flexible tracheobronchoscopy. Radiology 2007; 242:542.
49. Faust R.A., Remley K.B., and Rimell F.L.: Real-time, cine magnetic resonance imaging for evaluation of the pediatric airway. The
Laryngoscope 2001; 111: pp. 2187-2190
50. Lee K.S., Sun M.R., Ernst A., Feller-Kopman D., Majid A., and Boiselle P.M.: Comparison of Dynamic Expiratory CT With Bronchoscopy
for Diagnosing Airway Malacia: A Pilot Evaluation. Chest 2007; 131: pp. 758-764.